Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 60 and 90 years old and speak French
- Your doctor has recommended an MRI scan as part of investigating a possible Alzheimer's diagnosis
- Your doctor at a memory clinic has identified signs pointing toward Alzheimer's disease, based on specific memory and thinking tests (confirm with trial site)
- You scored 18 or above on a standard memory and thinking test called the MMSE
- You have shown a gradual decline in memory or thinking over at least the past 6 months
- You have given written agreement to take part after being fully informed about the trial
Who may not be able to join:
- You are unable to read or write, even partially
- You have a medical reason why you cannot safely have a 7 Tesla (high-strength) MRI scan
- You have a serious psychiatric condition that is not currently stable or well-controlled
- You have a neurological condition that is not related to brain degeneration, such as a stroke or multiple sclerosis
- You have a tumour, an inflammatory condition, or significant damage to the white matter of the brain seen on an MRI scan (confirm with trial site)
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 05.49.44.44.44
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To identify Magnetic Resonance Imaging biomarkers concentration (mmol/l) at baseline that are predictive of disability progression in individuals with Mild Alzheimer's disease as assessed by the Clinical Dementia Rating (CDR) scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.